Laparoscopic Placement of a Continuous Hepatic Artery Infusion Pump

Surgical Innovation

Volumn 7, Issue 2, 2000, Pages 140-147

  Urbach, David R ^a   Hansen, Paul D ^a  

^a LEGACY HEALTH SYSTEM   (United States)

Author keywords

Chemotherapy; Colorectal neoplasms; Hepatic artery; Intra arterial infusion therapy; Liver neoplasms; Metastases

Indexed keywords

ANTINEOPLASTIC AGENT;

COLORECTAL TUMOR; FEMALE; HEPATIC ARTERY; HUMAN; INFUSION PUMP; INTRAARTERIAL DRUG ADMINISTRATION; LAPAROSCOPY; LIVER TUMOR; MALE; METASTASIS; PATHOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; HEPATIC ARTERY; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; LAPAROSCOPY; LIVER NEOPLASMS; MALE;

MLCS; MLOWN;

EID: 84993737748     PISSN: 15533506     EISSN: None     Source Type: Journal    
DOI: 10.1177/155335060000700209     Document Type: Article

References (38)

1. Ries Lag, Kosary C.L., Hankey B.F., et al: SEER Cancer Statistics Review, 1973-1996. Bethesda, MD: National Cancer Institute, 1999
2. Weiss L., Grundmann E., Torhorst J., et al: Hematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies. J Pathol 150:195-203, 1986
3. August D.A.: Theoretic and experimental aspects of regional liver infusion. Surg Oncol Clin N Am 5:399-409, 1996
4. Ensminger W.D., Gyves J.W.: Regional chemotherapy of neoplastic diseases. Pharmacol Ther 21:277-293, 1983
5. Wagman L.D., Kemeny M.M., Leong L., et al: A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver.J Clin Oncol 8:1885-1893, 1990
6. Kemeny N., Daly J., Reichman B., et al: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 107:459-465, 1987
7. Chang A.E., Schneider P.D., Sugarbaker P.H., et al: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685-693, 1987
8. Hohn D.C., Stagg R.J., Friedman M.A., et al: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J Clin Oncol 7:1646-1654, 1989
9. Rougier P., Laplanche A., Huguier M., et al: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 10:1112-1118, 1992
10. Martin K.J., O'Connell M.J., Wieand H.S., et al: Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 125:1022-1027, 1990
11. Allen-Mersh T.G., Earlam S., Fordy C., et al: Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344:1255-1260, 1994
12. Harmantas A., Rotstein L.E., Langer B.: Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature. Cancer 78:1639-1645, 1996
13. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252-258, 1996
14. Begos D.G., Ballantyne G.H.: Regional chemotherapy for colorectal liver metastases: Thirty years without patient benefit. J Surg Oncol 56:139-144, 1994
15. Curley S.A., Hohn D.C., Roh M.: Hepatic artery infusion pumps: Cannulation techniques and other surgical considerations. Langenbecks Arch Chir 375:119-124, 1990
16. Frye J.W., Venook A.P., Ostroff J.W., et al: Hepatic intra-arterial methylene blue injection during endoscopy: A method of detecting gastroduodenal misperfusion in patients receiving hepatic intra-arterial chemotherapy via an implanted pump. Gastrointest Endosc 38:52-54, 1992
17. Cady B.: Hepatic arterial patency and complications after catheterization for infusion chemotherapy. Ann Surg 178:156-161, 1973
18. Campbell K.A., Burns R.C., Sitzmann J.V., et al: Regional chemotherapy devices: Effect of experience and anatomy on complications. J Clin Oncol 11:822-826, 1993
19. Cherqui D., Garden O.J., Bismuth H.: Duodenal erosion complicating an implanted hepatic arterial access device. Br J Surg 75:556, 1988
20. Clark R.A., Gallant T.E.: Bile duct strictures associated with hepatic arterial infusion chemotherapy. Gastrointest Radiol 12:148-151, 1987
21. Doria Mij, Doria L.K., Faintuch J., et al: Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine. A clinical and pathologic study. Cancer 73:2042-2047, 1994
22. Fukuzumi S., Moriya Y., Makuuchi M., et al: Serious chemical sclerosing cholangitis associated with hepatic arterial 5FU and MMC chemotherapy. Eur J Surg Oncol 16:251-255, 1990
23. Habbe T.G., McCowan T.C., Goertzen T.C., et al: Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapy. J Vasc Interv Radiol 9:233-239, 1998
24. Laughlin E.H. : Common duct stricture associated with hepatic artery infusion of FUDR.J Surg Oncol 31:56-59, 1986
25. Ottery F.D., Scupham R.K., Weese J.L.: Chemical cholecystitis after intrahepatic chemotherapy. The case for prophylactic cholecystectomy during pump placement. Dis Colon Rectum 29:187-190, 1986
26. Shepard K.V., Levin B., Faintuch J., et al: Hepatitis in patients receiving intraarterial chemotherapy for metastatic colorectal carcinoma. Am J Clin Oncol 10:36-40, 1987
27. Shike M., Gillin J.S., Kemeny N., et al: Severe gastroduodenal ulcerations complicating hepatic artery infusion chemotherapy for metastatic colon cancer. Am J Gastroenterol 81:176-179,1986
28. Kemeny N., Seiter K., Niedzwiecki D., et al: A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 69:327-334, 1992
29. Feliciotti F., Paganini A., Guerrieri M., et al: Laparoscopic intra-arterial catheter implantation for regional chemotherapy of liver metastases. Surg Endosc 10:449-452, 1996
30. Neuhaus S.J., Texler M., Hewett P.J., et al: Port-site metastases following laparoscopic surgery. Br J Surg 85:735-741, 1998
31. Chew D.K., Borromeo J.R., Kimmelstiel F.M.: Peritoneal mucinous carcinomatosis after laparoscopic-assisted anterior resection for early rectal cancer: Report of a case. Dis Colon Rectum 42:424-426, 1999
32. Clinical Outcomes of Surgical Therapy (COST) Study Group: Early results of laparoscopic surgery for colorectal cancer: retrospective analysis of 372 patients treated by Clinical Outcomes of Surgical Therapy (COST) study group. Dis Colon Rectum 39:S53-S58, 1996
33. Whelan R.L., Allendorf J.D., Gutt C.N., et al: General oncologic effects of the laparoscopic surgical approach. 1997 Frankfurt international meeting of animal laparoscopic researchers. Surg Endosc 12:1092-1095, 1998
34. Jones D.B., Guo L.W., Reinhard M.K., et al: Impact of pneumoperitoneum on trocar site implantation of colon cancer in hamster model. Dis Colon Rectum 38:1182-1188, 1995
35. Fleming R.Y., Dougherty T.B., Feig B.W.: The safety of helium for abdominal insufflation. Surg Endosc 11:230-234, 1997
36. Allendorf Jdf, Bessler M., Whelan R.L., et al: Differences in tumor growth after open vs. laparoscopic surgery are lost in an athymic model and are associated with differences in tumor proliferative index. Surg Endosc 12:1092-1095, 1998
37. Jacobi C.A., Wenger F., Sabat R., et al: The impact of laparoscopy with carbon dioxide versus helium on immunologic function and tumor growth in a rat model. Dig Surg 15:110-116,1998
38. Bouvy N.D., Marquet R.L.,Jeekel J., et al: Laparoscopic surgery is associated with less tumour growth stimulation than conventional surgery: An experimental study. Br J Surg 84:358-361, 1997